
ãã€ãã¯2020å¹Žã®æ©ãææã«COVIDã©ãã®ãªãŒã¯ãç¥ã£ãŠããããåœæ°ãã蚌æ ãé ããŠãã
å èšäºã¯ãã¡ããã/Click here to read the original article.
æ°Žææ¥ã«çºè¡šããããã€ãã®èª¿æ»å ±åæžã«ããã°ããã€ãã®å¯Ÿå€æ å ±æ©é¢ã¯2020幎ãCOVID-19ãã³ãããã¯ã®çºçãäžåœã®æŠæŒ¢ãŠã€ã«ã¹åŠç ç©¶æã®ç 究宀æŒãã«ç«¯ãçºããŠããããšã80ïŒ ãã95ïŒ ã®ç¢ºåºŠã§æå®ããã
ãã€ãã®å¯Ÿå€æ å ±æ©é¢ã§ããBNDã¯2020幎ãCOVID-19ãã³ãããã¯ã®çºçãäžåœã®æŠæŒ¢ãŠã€ã«ã¹åŠç ç©¶æã®ç 究宀ããã®æ å ±æŒæŽ©ã«ç«¯ãçºããŠãããš80ïŒ ã95ïŒ ã®ç¢ºåºŠã§æå®ããã
Die ZeitããšãSÃŒddeutsche Zeitungããæ°Žææ¥ã«å ±åã§çºè¡šãããã®å ±åæžã¯ã1幎åã«ããã調æ»ã®çµæã§ããã
調æ»ã«ãããšã2020幎ãåœæã®ã¢ã³ã²ã©ã»ã¡ã«ã±ã«ç¬éŠçžã¯ãBNDïŒãã€ãæ å ±å±ïŒã«ããµãŒã¬ããŒèšç»ããšããã³ãŒãããŒã ã§ãäžåœã®æ©é¢ãç ç©¶æ©é¢ãæšçã«ããäœæŠãäŸé Œããã
BNDã®èª¿æ»ã«ãããæŠæŒ¢ã®ç ç©¶æã®æ å ±æŒãããCOVID-19ãã³ãããã¯ã®æãå¯èœæ§ã®é«ãåå ã§ãããšçµè«ä»ãããããšãã¡ã«ã±ã«æ¿æš©ã¯ã¹ãã€æ©é¢ããã®çµæãå ¬è¡šããããšãçŠããã
2023幎ãã¡ã«ã±ã«éŠçžã®åŸä»»ã®ãªã©ãã»ã·ã§ã«ãéŠçžãBNDã®èª¿æ»çµæã®å ¬è¡šãæåŠããã
ãžã£ãŒãã³ã»ã¬ãã¥ãŒãèªã«ããã°ãã¡ã«ã±ã«ãšã·ã§ã«ãã¯ãã®æ å ±ã ãå®å šã«æç¢ºã§ã¯ãªãçç±ã§ ãç§å¯ã«ããŠããã
ã¢ã³ã²ã©ã»ã¡ã«ã±ã«ïŒCDUïŒçãã倧é£ç«æ¿æš©ãšããªã©ãã»ã·ã§ã«ãïŒSPDïŒçãã ã人身売買é£å ãæ¿æš©ã®äºä»£ç¶ããé£éŠæ¿åºã¯ãBNDã«å£æ¢ããããã®ã ãããïŒ
COVID-19ã¯ã人ç£å ±éææçããã€ãŸãåç©ãããããžã®ææã®çµæã§ãããšçµè«ã¥ããè«æãProximal Originãã2020幎ã«ãã€ãã£ãŒã»ã¡ãã£ã·ã³èªã«çºè¡šãããããã§ããã
ç±³åœäžé¢ã®å ±åæžã«ãããšãã¢ã³ãœããŒã»ãã¡ãŠãå士ããProximal Originãè«æã®èµ·èãšãã®åŸã®çºè¡šã«ãããŠéèŠãªåœ¹å²ãæãããŠããããšã倿ããã
調æ»å ±åæžã«ãããšããã€ãæ¿åºã¯2024幎æ«ã«çªç¶æ 床ãå€ãããBNDããã€ãé£éŠè°äŒãšäžçä¿å¥æ©é¢ïŒWHOïŒã«èª¿æ»çµæãå ±åããããšãèªããã®ã ã
ãã€ãæ¿åºã¯ãŸããè«äºã®çãšãªã£ãŠããæ©èœç²åŸç ç©¶ã«å¯Ÿãã峿 ŒãªäžççèŠå¶ãæå±ããäºå®ã§ããããã®ãããªç ç©¶ã¯ããŠã€ã«ã¹ã®æææ§ãç åæ§ãå¢å ããããã®ã§ããã°ãã°ã¯ã¯ãã³éçºã«å©çšãããSARS-CoV-2ãŠã€ã«ã¹ã®éçºã«ã€ãªãã£ãå¯èœæ§ãããã
çå®ãæããã«ããããã®é·ãéã®ãã®æ°ããªäžæ©
ããã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºãçŽã®å ç§åŠç·šéè ããã³ã©ã¹ã»ãŠã§ã€ãæ°ã¯ããã€ãã®æ°ããå ±åæžã«ã€ããŠããå®éšå®€ããã®æŒåºèª¬ãæ°ããªçµç¹ã§æ¡çšããããã³ã«ãçå®ã®è§£æã«åããé·ãéã®ãã®æ°ããªäžæ©ãèžã¿åºãããããšã«ãªãããšè¿°ã¹ãã
ãŠã§ã€ãæ°ã¯ã人ç£å ±éææç説ã¯ç§åŠç粟æ»ã«èããããªããšè¿°ã¹ãããç§ã®èŠè§£ã§ã¯ã人ç£å ±éææèª¬ãæ¯æãããã£ãšãããã蚌æ ã¯äœãåºãŠããŠããªãã人ç£å ±éææèª¬ãæ¯æãããã£ãšãããã蚌æ ã¯äœãåºãŠããŠããªãã
圌ã¯ãã»ãšãã©ã®æ¿æ²»è©è«å®¶ã¯ ãç§åŠã«äžå®ãæããŠãããæ¿æ²»çæ ¹æ ã§ãããã®åé¡ãè©äŸ¡ã§ããªã ããšè¿°ã¹ãã
æ©èœç²åŸç ç©¶ãæ¹å€ããã©ãã¬ãŒã¹å€§åŠã®ååçç©åŠè ãªãã£ãŒãã»ãšãã©ã€ãå士ã¯ããæ å ±éã¯äŸå€ãªãã2020幎åé ã«ã¯SARS-CoV-2ãæŠæŒ¢ã®ç ç©¶é¢é£äºä»¶ãéããŠããã«ææããå¯èœæ§ãé«ãããšãç¥ã£ãŠãããããããã»ãšãã©ã®è ã¯åãã€ãããæ²é»ãå®ãããšãéžãã ã
ãã®äžã«ã¯ç§åŠçã ãã§ãªããã¢ã¡ãªã«ãšãã€ãã®æ å ±æ©é¢ãå«ãŸããŠããããšãšãã©ã€ãã¯èšãã
ãŠã©ãŒã«ã»ã¹ããªãŒãã»ãžã£ãŒãã«çŽã¯æšå¹ŽãFBIã¯2021幎ã«ãŠã€ã«ã¹ãç ç©¶æããæµåºãããšãã蚌æ ãæã£ãŠãããããããçºè¡šããããšã¯èš±ãããªãã£ããšå ±ããã
調æ»ãžã£ãŒããªã¹ãã®ããŒã«ã»Dã»ãµãã«ãŒæ°ã¯ãã¢ã¡ãªã«ã®äž»èŠãªå ±éæ©é¢ã¯ãã€ãã®èª¿æ»ãå ±éããŠããªããšè¿°ã¹ãã
æ°Žææ¥ã®èšè äŒèŠã§ãã·ã§ã«ãã¯èª¿æ»å ±åæžã«ã€ããŠã®ã³ã¡ã³ããé¿ãããã¡ã«ã±ã«éŠçžãšãã€ãæ å ±å±ã®ä»£è¡šãã³ã¡ã³ããæåŠããã
BNDãæŠæŒ¢ã®ç ç©¶æãæ å ±æŒæŽ©ã«ã€ããŠãç°åžžã«å€ãã®ç¥èããæã£ãŠããããšãçºèŠ
ãŠã€ã«ã¹åŠè ãå«ãBNDã®èª¿æ»å¡ã°ã«ãŒãã¯ã2020幎åãã«COVID-19ã®èµ·æºã調æ»ããä»»åãè² ã£ããææ»å®ãã¡ã¯æŠæŒ¢ã§ãéé±ãæãåœãŠãããæŠæŒ¢ãŠã€ã«ã¹åŠç ç©¶æã§ã®æŒæŽ©ã瀺åãããæªçºè¡šããŒã¿ãšå éšææžããçºèŠããã®ã§ããã
ææ»å®ã¯ãã³ãããŠã€ã«ã¹ãæ±ã£ãäžé£ã®æž¬å®ãšããŒã¿ãåç©å®éšãš2019幎ãš2020å¹Žã®æªçºè¡šè«æãå«ãããã€ãã®ç§åŠç ç©¶ã«é¢ããæ å ±ãçºèŠãããåå£«è«æã¯ã³ãããŠã€ã«ã¹ã人éã®è³ã«åãŒã圱é¿ãæ±ã£ãŠãããšãããŠããã
ãŸããæŠæŒ¢ã®ç ç©¶æã®ã»ãã¥ãªãã£å¯Ÿç㯠ãé©ãã»ã©çãã£ã ããšãããBNDãçºèŠããè³æã¯ããæŠæŒ¢ã§ã¯ãæ°åãšæããããŠã€ã«ã¹ã«é¢ããç°åžžã«å€ãã®ç¥èããç°åžžã«æ©ã段éã§å ¥æå¯èœã§ãã£ãããšã瀺åããŠãããã
BNDã¯ããã®èª¿æ»çµæãããæ å ±ã®ä¿¡é Œæ§ã®å°ºåºŠ ããšããŠç¥ããã ãç¢ºçææ° ããšåŒã°ããã³ã³ãã¥ãŒã¿ãŒã¢ãã«ã«ãããããã®ã¢ãã«ã¯ãBNDã®èª¿æ»çµæããæŠæŒ¢ã®ç ç©¶æã§æŒæŽ©ãèµ·ãã£ãããšã80ïŒ ãã95ïŒ ã®ç¢ºåºŠã§ç€ºããŠãããšè¿°ã¹ãã
BNDã¯ãã®èª¿æ»çµæã2020幎åŸåã«ãã€ãéŠçžå®éžããããŠã¡ã«ã±ã«éŠçžæ¬äººã«å ±åãããããããå ±åæžã«ããã°ããã€ãéŠçžåºã¯ ã2ã€ã®åé¡ ããææãããBNDã®èª¿æ»çµæã® ãä¿¡é Œæ§ ãã«çåãåãããŸããç±³äžéã®å°æ¿åŠç察ç«ã«ä»å ¥ããããšã«æ¶æ¥µçã§ãã£ãã
ããã€ãæ¿åºã¯2ã€ã®äžççã©ã€ãã«ã®éã«æãŸãããã®å¯Ÿç«ã¯äžççãªæ¿æ²»çççºãšãªãå¯èœæ§ãç§ããŠããããããŠããã®çãäžã«ããŒã¿ãææžãè§£éãæã€BNDãç«ã£ãŠããããšå ±åæžã¯è¿°ã¹ãŠããããã®çµæããéŠçžåºã¯äœãããªãããšã決å®ãããBNDã¯ ãæ²é»ãèªãããããã
ãã€ãè©ãèªã«ããã°ããã®æ±ºå®ã®æ¿æ²»çè«çã¯ãçè§£ã§ããããããããªãããBNDã®èª¿æ»çµæãç§å¯ã«ãããšããæ±ºå®ã¯ããäžçä¿å¥æ©é¢ïŒWHOïŒããã³ãããã¯ã®åå ç©¶æã«åœ¹ç«ã€ãããªãæ å ±ãäŒããããšãã蚎ããç¡èŠããããšãæå³ãããã
ãã®æ²é»æ¿çã¯ã2021幎æ«ã«èªçããã·ã§ã«ãæ°æ¿æš©ã§ãç¶ããã調æ»å ±åæžã«ããã°ãã·ã§ã«ãéŠçžãä»»åœããã³ãããŠã€ã«ã¹ã®ãã³ãããã¯ã«é¢ããå°éå®¶äŒè°ã33åãéãããã«ãããããããBNDã®èª¿æ»çµæãç¥ãããšã¯ãªãã£ãã
ãã€ãæ¿åºã¯ã2023幎2æã«ç±³ãšãã«ã®ãŒçãã3æã«FBIããSARS-CoV-2ã¯å®éšå®€ããã®æµåºãåå ã§ããå¯èœæ§ãé«ããšçºè¡šããåŸãããã®å§¿å¢ãç¶æããã
2024幎12æããã€ãé£éŠæ å ±å±ã¯ç§åŠè ãè«å ±æ©é¢ãšèª¿æ»çµæãå ±æããããšãèš±å¯ãããã2025幎1æã«çºè¡šãããCIAã®å ±åæžã¯ãCOVID-19ã¯æŠæŒ¢ã®ç ç©¶æããçºçããå¯èœæ§ãé«ããšçµè«ã¥ããã
ãã€ãã®èª¿æ»å ±åæžã«ãããšãBNDã¯ãã®1ã«æåã«CIAãšèª¿æ»çµæãå ±æããŠããã
ããã«ãªã³ã§ã¯ãBNDã®æ å ±ã¯CIAãå®éšå®€èª¬ãæ éã«æ¡çšããã®ã«è²¢ç®ãããšç¢ºä¿¡ããŠããããšèª¿æ»å ±åæžã¯è¿°ã¹ãŠããã
ãã€ãã®äž»èŠãŠã€ã«ã¹åŠè ãæŠæŒ¢ã®ãã³ãŠã¢ãªå¥³ããšå ±åç ç©¶
ãã€ãã®èª¿æ»å ±åæžã«ããã°ã2024幎12æãBNDã¯ã¯ãªã¹ãã£ã³ã»ããã¹ãã³å士ãšèª¿æ»çµæãå ±æããã
ãžã£ãŒãã³ã¬ãã¥ãŒçŽã«ããã°ãããã¹ãã³æ°ã¯ããã€ãã§ã®ãã³ãããã¯æã«åœ±é¿åã®ãã£ãå ¬äººã§ãããCOVID-19é¢é£ã®ããããã£ã¹ãããäœçŸäžäººããèããŠããããã¹ãã§ãã£ããã人ç£å ±éææèª¬ã®æ¯æè ã§ãããæŠæŒ¢ã®ç§åŠè ãã¡ãšã€ãªãã£ãŠããã
ãã€ãã®èª¿æ»å ±åæžã«ããã°ãããã¹ãã³ã¯ãæ©èœç²åŸç ç©¶ã®ãããŒæŽ»åã«æ·±ãé¢äžãããŠããããã³ãŠã¢ãªå¥³ããšããŠåºãç¥ãããŠããã·ãŒã»ãžã§ã³ãªå士ãšãã现èå¹é€ã«é©å¿ãããŠã€ã«ã¹ã«é¢ããå ±åç ç©¶ãè¡ã£ãŠããã
ãã€ãã®èª¿æ»å ±åæžã¯ãæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æãæ©èœç²åŸç ç©¶ã«åŸäºããŠããããšãæããã«ãããæ£åã¯æŠæŒ¢ç ç©¶æãçããæ©èœç²åŸç ç©¶ã®ããã«ç±³åœç«è¡çç ç©¶æïŒNIHïŒããè³éæŽå©ãåããŠããã
å ±åæžã«ããã°ãæ©èœç²åŸç ç©¶ã¯ãã€ãªã¹ã¯ã§ããããæªçšãããå¯èœæ§ã¯é«ãã責任ãšç¡è²¬ä»»ã®å¢çç·ã¯èãããããããã®ç ç©¶æã¯çŸåšããã®ãããªç ç©¶ãç¶ããããšã«ãã£ãŠããå¢çç·ãèžã¿è¶ããŠãããããã«èŠããã
ç¬ãè©è«ãã¯ãCOVID-19ã®ãã³ãããã¯ã®éãããã¹ãã³ã¯ç ç©¶æã®ãªãŒã¯ã¯ ãæ¥µããŠããåŸãªã ããšè¿°ã¹ããšææãããããããå æãã€ãã®æ°èTazãšã®ã€ã³ã¿ãã¥ãŒã®äžã§ãããã¹ãã³ã¯ãã®çºèšãæ€åããããå®éšå®€ç±æ¥ã®èšŒæ ããªãã®ãšåæ§ã«ãèªç¶ç±æ¥ã®èšŒæ ããªãããšåœŒã¯èªã£ãã
ãšãã©ã€ãæ°ã«ããã°ãBNDã®èª¿æ»çµæã¯ãæ©èœç²åŸç ç©¶ãçŠæ¢ããããæ±ãã声ã匷ãããã®ã ãšããã
ãæœåšçãªãã³ãããã¯ç åäœã«é¢ããæ©èœç²åŸç ç©¶ã¯COVIDãã³ãããã¯ãåŒãèµ·ããããç±³åœã¯ãæœåšçãã³ãããã¯ç åäœã«é¢ããæ©èœç²åŸç ç©¶ãçŠæ¢ããæœåšçãã³ãããã¯ç åäœã«é¢ããæ©èœç²åŸç ç©¶ã®åœéççŠæ¢ãæå±ãã¹ãã§ããã